Niki BioSolutions, Inc. (NIKI) Cash from Operations (2017 - 2025)
Niki BioSolutions' (NIKI) quarterly Cash from Operations came in at 43423.0 in Q4 2025, up 49.1% YoY from 29123.22 in Q4 2024, and up 74.69% on a QoQ basis from 171585.0 in Q3 2025.
Niki BioSolutions, Inc. (NIKI) Cash from Operations (2017 - 2025) Analysis & Trends
Niki BioSolutions (NIKI) has 3 years of Cash from Operations data on file, last reported at 43423.0 in Q4 2025.
- Quarterly Cash from Operations rose 49.1% year-over-year to 43423.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was 360869.0 (changed N/A YoY) and the FY2025 annual result came in at 1836546.0, down 54.37% from the prior year.
- Cash from Operations improved to 43423.0 in Q4 2025, from 171585.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 43423.0 in Q4 2025 to a low of 171585.0 in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | -43,423.00 |
| Nov 30, 2025 | -43,423.00 |
| Aug 31, 2025 | -171,585.00 |
| Aug 31, 2025 | -171,585.00 |
| Nov 30, 2024 | -85,312.00 |
| Nov 30, 2024 | -85,312.00 |
| Aug 31, 2024 | -60,549.00 |
| Aug 31, 2024 | -60,549.00 |
| Dec 31, 2017 | -5.78 Mn |
| Dec 31, 2017 | -5.78 Mn |